Related references
Note: Only part of the references are listed.Immune microenvironment in different molecular subtypes of ductal breast carcinoma
Mona Sadeghalvad et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Immunohistochemical analysis of the aggregation of CD1a-positive dendritic cells in resected specimens and its association with surgical outcomes for patients with gallbladder cancer
Keita Kai et al.
TRANSLATIONAL ONCOLOGY (2021)
Tumor-Infiltrating CD1a+ DCs and CD8+/FoxP3+ Ratios Served as Predictors for Clinical Outcomes in Tongue Squamous Cell Carcinoma Patients
Yan-Hong Ni et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
The CD83 Molecule - An Important Immune Checkpoint
Linda Grosche et al.
FRONTIERS IN IMMUNOLOGY (2020)
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
Paula Michea et al.
NATURE IMMUNOLOGY (2018)
Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer
Vivian Labovsky et al.
TUMOR BIOLOGY (2016)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
E. Senkus et al.
ANNALS OF ONCOLOGY (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
CD1a-positive dendritic cell density predicts disease-free survival in papillary thyroid carcinoma
Ohad Hilly et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
Leandro Marcelo Martinez et al.
PLOS ONE (2015)
Tumor-stroma crosstalk: targeting stroma in breast cancer
Carmen Criscitiello et al.
CURRENT OPINION IN ONCOLOGY (2014)
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Paolo Cirri et al.
CANCER AND METASTASIS REVIEWS (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells
Julien Faget et al.
CANCER RESEARCH (2012)
CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation
Lina E. Tze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
CD1a and CD1d Genes Polymorphisms in Breast, Colorectal and Lung Cancers
Hossein Golmoghaddam et al.
PATHOLOGY & ONCOLOGY RESEARCH (2011)
The microenvironment in breast cancer progression: biology and implications for treatment
Andrew E. Place et al.
BREAST CANCER RESEARCH (2011)
Recent advances in processing and presentation of CD1 bound lipid antigens
Mariolina Salio et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Interleukin-6 in bone metastasis and cancer progression
Tasnim Ara et al.
EUROPEAN JOURNAL OF CANCER (2010)
Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth
Albert Lin et al.
IMMUNOLOGY LETTERS (2010)
Inhibition of Interleukin-6 Receptor Directly Blocks Osteoclast Formation In Vitro and In Vivo
Roland Axmann et al.
ARTHRITIS AND RHEUMATISM (2009)
Presentation of lipid antigens to T cells
Lucia Mori et al.
IMMUNOLOGY LETTERS (2008)
CD83: an update on functions and prospects of the maturation marker of dendritic cells
Alexander T. Prechtel et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
Inflammation and breast cancer - Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G. DeNardo et al.
BREAST CANCER RESEARCH (2007)
CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Differential lysosomal proteolysis in antigen-presenting CeRs determines antigen fate
L Delamarre et al.
SCIENCE (2005)
CD1a in human cancers: a new role for an old molecule
B Coventry et al.
TRENDS IN IMMUNOLOGY (2004)
CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer
BJ Coventry et al.
BRITISH JOURNAL OF CANCER (2003)
Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas
M Iwamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism
O Kudo et al.
BONE (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation
CC Sombroek et al.
JOURNAL OF IMMUNOLOGY (2002)
NKT cells - conductors of tumor immunity?
MJ Smyth et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Dendritic cell density and activation status in human breast cancer - CD1a, CMRF-44, CMRF-56 and CD-83 expression
BJ Coventry et al.
BRITISH JOURNAL OF CANCER (2002)
Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer
A Eisenthal et al.
HUMAN PATHOLOGY (2001)
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
P Chomarat et al.
NATURE IMMUNOLOGY (2000)
Share Paper
